ChristopherGPetersonMD

Oncology • Wausau, WI

Vice Chairman, Aspirus, Inc.

Join to view full profile

Are you Dr. Peterson?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 56 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
333 Pine Ridge Blvd
Wausau, WI 54401
Phone+1 715-847-2866
Is this information wrong?

Summary

Dr. Christopher Peterson, MD is an oncologist in Wausau, Wisconsin. He is currently licensed to practice medicine in Wisconsin and Michigan. He is affiliated with Aspirus Wausau Hospital, Inc., Aspirus Langlade Hospital, and Oscar G. Johnson Department of Veterans Affairs Medical Facility.

Education & Training

University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2003 - 2005
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 2001 - 2003
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1998 - 2001
Medical College of WisconsinClass of 1998

Certifications & Licensure

MI State Medical License 2011 - 2025
WI State Medical License 1999 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
Completed
Phase 3
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Start of enrollment: 2008 Mar 01
Active, not recruiting
Phase 3
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
Completed
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2009 Jul 15
Terminated
Phase 3
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Start of enrollment: 2010 Jun 01
Completed
Phase 3
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Active, not recruiting
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09
Active, not recruiting
Phase 3
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma.
Kahl, B., Jegede, O., Habermann, T., Schuster, S., Weiss, M., Fenske, T., Peterson, C., Swinnen, L., Fishkin, P., Williams, M.> ;Journal of Clinical Oncology. 2024 Mar 1
11 citations
VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.
Julie E. Chang, Lakeesha Carmichael, KyungMann Kim, Christopher Peterson, David T. Yang, Anne M. Traynor, Jae Werndli, Michael S. Huie, Thomas McFarland, Michael Volk,...> ;Clinical Lymphoma, Myeloma & Leukemia. 2018 Jan 1
28 citations
Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protoco...
Michael E. Williams, Fangxin Hong, Randy D. Gascoyne, Lynne I. Wagner, John C. Krauss, Thomas M. Habermann, Lode J. Swinnen, Stephen J. Schuster, Christopher Peterson,...> ;British Journal of Haematology. 2016 Jun 1
135 citations
Rituximab Extended Schedule or Re-Treatment Trial for Low–Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402
Brad S. Kahl, Fangxin Hong, Michael E. Williams, Randy D. Gascoyne, Lynne I. Wagner, John C. Krauss, Thomas M. Habermann, Lode J. Swinnen, Stephen J. Schuster, Christo...> ;Journal of Clinical Oncology. 2014 Oct 1
3 citations
Yttrium 90-ibritumomab tiuxetan plus rituximab maintenance as initial therapy for patients with high-tumor-burden follicular lymphoma: a Wisconsin Oncology Network study.
Saurabh Rajguru, Thorhildur Kristinsdottir, Jens C. Eickhoff, Christopher Peterson, Christine M. Meyer, Anne M. Traynor, Brad S. Kahl> ;Clinical Advances in Hematology & Oncology. 2014 Aug 1
Assessing psychological well-being: self-report instruments for the NIH Toolbox.
Salsman, J. M.,Lai, J. S.,Hendrie, H. C.,Butt, Z.,Zill, N.,Pilkonis, P. A.,Peterson, C.,Stoney, C. M.,Brouwers, P.,Cella, D.> ;Qual Life Res. 2013 Jun 19
Development, testing, and deployment of an air sampling manifold for spiking elemental and oxidized mercury during the Reno Atmospheric Mercury Intercomparison Experim...
Finley BD, Jaffe DA, Call K, Lyman S, Gustin MS, Peterson C, Miller M, Lyman T> ;Environ. Sci. Technol.. 2013-07-02
44 citations
VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study
Julie E. Chang, Christopher Peterson, Sangbum Choi, Jens C. Eickhoff, KyungMann Kim, David T. Yang, Leslie A. Gilbert, Eric S. Rogers, Jae Werndli, Michael S. Huie, Th...> ;British Journal of Haematology. 2011 Oct 1
12 citations
Development of associations between microalgae and denitrifying bacteria in streams of contrasting anthropogenic influence.
Christopher G. Peterson, Allison D. Daley, Shannon M. Pechauer, Kathryn N. Kalscheur, Malachy J. Sullivan, Samantha L. Kufta, Miguel Rojas, Kimberly A. Gray, John J. K...> ;FEMS Microbiology Ecology. 2011 Sep 1
20 citations
Influence of Algal Community Structure on Denitrification Rates in Periphyton Cultivated on Artificial Substrata
Cari K. Ishida, Shai Arnon, Christopher G. Peterson, John J. Kelly, Kimberly A. Gray> ;Microbial Ecology. 2008 Jul 1
7 citations
Influence of flow conditions and system geometry on nitrate use by benthic biofilms: implications for nutrient mitigation.
Shai Arnon, Christopher G. Peterson, Kimberly A. Gray, Aaron I. Packman> ;Environmental Science & Technology. 2007 Dec 1
6 citations
Follicular lymphoma: management options in the era of targeted therapy.
Christopher Peterson, Brad S. Kahl> ;Current Treatment Options in Oncology. 2005 Jul 1
18 citations
Combined Modality Treatment for Central Nervous System Malignancies
H. Ian Robins, Christopher Peterson, Minesh P. Mehta> ;Seminars in Oncology. 2003 Aug 1
Join now to see all

Hospital Affiliations

Aspirus Ironwood HospitalIronwood, Michigan
Aspirus Wausau Hospital, Inc.Wausau, Wisconsin
Aspirus Langlade HospitalAntigo, Wisconsin
Oscar G. Johnson Department of Veterans Affairs Medical FacilityIron Mountain, Michigan